Open AccessPeripheral naïve CD8 + T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
Author(s) -
Huang Cheng,
Xu Bin,
Zhu XiaoDong,
Shen YingHao,
Li MeiLing,
Zhu JinJin,
Zhou Jian,
Fan Jia,
Sun HuiChuan
Publication year - 2022
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1002/cac2.12350
Subject(s) - medicine , lenvatinib , oncology , hepatocellular carcinoma , atezolizumab , immunotherapy , biomarker , nivolumab , cancer , sorafenib , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom